Health Catalyst Inc
For the period ended Jun 30, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 8, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a) None.
(b) None.
(c) During the three months ended June 30, 2024, the following directors or officers of the Company adopted a “Rule 10b5-1 trading arrangement”, as defined in Item 408(a) of Regulation S-K:
| Name and Title | Type of Trading Arrangement | Date Adopted | Expiration Date | Duration(1) | Total Shares to be Sold |
|---|---|---|---|---|---|
| Duncan Gallagher, Director | Rule 10b5-1 Trading Arrangement | 5/26/2024 | 12/31/2024 | 219 | 9,000 |
(1)The Rule 10b5-1 trading arrangement permits transactions through and including the earlier to occur of (a) completion of all sales or (b) the expiration date listed in the table.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.